FIELD: medicine.
SUBSTANCE: method involves applying plasma exchange course with cryosorption treatment of 2.5-3 volumes of circulating blood plasma within a course.
EFFECT: enhanced effectiveness in removing cytotoxic CD8+ lymphocytes, tumor necrosis factor α and interleukine-4; selective immunocorrection.
3 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR ONCOLOGICAL DISEASES COURSE PREDICTION | 2016 |
|
RU2622756C1 |
| METHOD FOR TREATMENT OF MULTISYSTEM INFLAMMATORY SYNDROME IN CHILDREN ASSOCIATED WITH SARS-CoV-2 | 2021 |
|
RU2780939C1 |
| METHOD OF REGENERATIVE TREATMENT OF GIRLS-TEENAGERS WITH CHRONIC SALPINGO-OPHORITIS | 2007 |
|
RU2343941C1 |
| METHOD OF MEDICAL REHABILITATION OF ADOLESCENT GIRLS WITH ACUTE COMPLICATED SALPINGOOPHORITE | 2007 |
|
RU2349328C1 |
| CEREBRAL ATHEROSCLEROSIS TREATMENT METHOD | 2000 |
|
RU2195321C2 |
| METHOD OF TREATING DISSEMINATED LICHEN ACUMINATUS ASSOCIATED WITH CHRONIC GRANULOMATOUS PERIODONTITIS | 2019 |
|
RU2703313C1 |
| METHOD FOR BODY DETOXIFICATION IN CRITICAL ENDOTOXICOSES | 2009 |
|
RU2395304C1 |
| METHOD OF HEPATITIS TYPE C TREATMENT | 2006 |
|
RU2336096C1 |
| METHOD OF TREATING PATIENT WITH CHRONIC BRUCELLOSIS | 2009 |
|
RU2423143C2 |
| METHOD FOR CONTINUOUS PLASMAPHERESIS IN NEONATALS | 2001 |
|
RU2208455C2 |
